CUP Belumosudil

Section NCT
Category Hematological neoplasms
Subcategory Other indications (e.g. myeloproliferative diseases)
Trial Type other systemic therapies
Description for experts For the treatment chronic graft-versus-host disease (cGvHD) in adult patients after failure of at least two previous lines of systemic therapy
Description for laymen For the treatment chronic graft-versus-host disease (cGvHD) in adult patients after failure of at least two previous lines of systemic therapy
JSON Data { "short_title": "CUP Belumosudil", "data_mode": "910", "data_mode_number": "000000057", "official_title": null, "accrual_state": "running", "therapeutic_value": "not_applicable", "therapieansatz_value": "not_applicable", "therapieintervention_value": "not_applicable", "therapielinie_value": "not_applicable", "ctgov_number": null, "eudract_number": null, "general_contact_email": "sal-aml-register@ukdd.de", "general_contact_phone": "+49 351-45818380", "hauptpruefer_dd_name": null, "description_laie_de": "Zur Behandlung der chronischen Graft-versus-Host-Krankheit (cGvHD) bei erwachsenen Patienten nach Versagen von mindestens zwei vorherigen systemischen Therapielinien", "description_laie_en": "For the treatment\nchronic graft-versus-host disease (cGvHD) in adult patients after\nfailure of at least two previous lines of systemic therapy", "description_expert_de": "Zur Behandlung der chronischen Graft-versus-Host-Krankheit (cGvHD) bei erwachsenen Patienten nach Versagen von mindestens zwei vorherigen systemischen Therapielinien", "description_expert_en": "For the treatment\nchronic graft-versus-host disease (cGvHD) in adult patients after\nfailure of at least two previous lines of systemic therapy", "rechtsgrundlage_value": null, "phase_amg_value": null, "main_cat_id": 4, "sub_cat_id": 22 }
Settings
Short name 910-000000057